X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2017 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Compare FDC LTD. with Aurobindo Pharma - Equitymaster
  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

FDC LTD. vs AUROBINDO PHARMA - Comparison Results

AUROBINDO PHARMA 
   Change

Aurobindo Pharma is one of India's top 5 pharma companies in terms of turnover, and has presence in the generic and Active Pharmaceutical Ingredients (API) segments. The company's robust product portfolio is spread across 6 product areas, including a... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    FDC LTD. AUROBINDO PHARMA FDC LTD./
AUROBINDO PHARMA
 
P/E (TTM) x 17.2 17.7 96.8% View Chart
P/BV x 3.6 5.8 62.1% View Chart
Dividend Yield % 1.3 0.4 367.8%  

Financials

 FDC LTD.   AUROBINDO PHARMA
EQUITY SHARE DATA
    FDC LTD.
Mar-14
AUROBINDO PHARMA
Mar-16
FDC LTD./
AUROBINDO PHARMA
5-Yr Chart
Click to enlarge
High Rs1441,541 9.3%   
Low Rs79582 13.6%   
Sales per share (Unadj.) Rs47.6237.5 20.0%  
Earnings per share (Unadj.) Rs7.633.9 22.5%  
Cash flow per share (Unadj.) Rs9.040.6 22.2%  
Dividends per share (Unadj.) Rs2.252.50 90.0%  
Dividend yield (eoy) %2.00.2 858.6%  
Book value per share (Unadj.) Rs47.5120.6 39.4%  
Shares outstanding (eoy) m177.83585.17 30.4%   
Bonus/Rights/Conversions BBPREF-  
Price / Sales ratio x2.34.5 52.3%   
Avg P/E ratio x14.631.3 46.7%  
P/CF ratio (eoy) x12.326.2 47.2%  
Price / Book Value ratio x2.38.8 26.6%  
Dividend payout %29.67.4 400.6%   
Avg Mkt Cap Rs m19,784621,041 3.2%   
No. of employees `000NA13.3 0.0%   
Total wages/salary Rs m1,22115,508 7.9%   
Avg. sales/employee Rs ThNM10,457.6-  
Avg. wages/employee Rs ThNM1,167.1-  
Avg. net profit/employee Rs ThNM1,491.6-  
INCOME DATA
Net Sales Rs m8,459138,961 6.1%  
Other income Rs m3941,663 23.7%   
Total revenues Rs m8,852140,624 6.3%   
Gross profit Rs m2,07032,056 6.5%  
Depreciation Rs m2493,926 6.3%   
Interest Rs m312,568 1.2%   
Profit before tax Rs m2,18427,225 8.0%   
Minority Interest Rs m039 0.0%   
Prior Period Items Rs m-2250-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m6067,444 8.1%   
Profit after tax Rs m1,35319,820 6.8%  
Gross profit margin %24.523.1 106.1%  
Effective tax rate %27.727.3 101.4%   
Net profit margin %16.014.3 112.2%  
BALANCE SHEET DATA
Current assets Rs m4,355100,015 4.4%   
Current liabilities Rs m1,79274,759 2.4%   
Net working cap to sales %30.318.2 166.7%  
Current ratio x2.41.3 181.7%  
Inventory Days Days44107 41.4%  
Debtors Days Days25110 22.5%  
Net fixed assets Rs m3,02552,350 5.8%   
Share capital Rs m179585 30.5%   
"Free" reserves Rs m8,24367,707 12.2%   
Net worth Rs m8,45370,567 12.0%   
Long term debt Rs m118,472 0.1%   
Total assets Rs m10,557156,994 6.7%  
Interest coverage x71.411.6 615.5%   
Debt to equity ratio x00.1 1.1%  
Sales to assets ratio x0.80.9 90.5%   
Return on assets %13.114.3 91.9%  
Return on equity %16.028.1 57.0%  
Return on capital %23.537.7 62.3%  
Exports to sales %13.351.0 26.1%   
Imports to sales %3.318.8 17.7%   
Exports (fob) Rs m1,12670,927 1.6%   
Imports (cif) Rs m28326,193 1.1%   
Fx inflow Rs m1,14671,015 1.6%   
Fx outflow Rs m35528,799 1.2%   
Net fx Rs m79142,216 1.9%   
CASH FLOW
From Operations Rs m1,48517,596 8.4%  
From Investments Rs m-620-13,801 4.5%  
From Financial Activity Rs m-753-198 379.5%  
Net Cashflow Rs m1133,597 3.1%  

Share Holding

Indian Promoters % 68.9 54.1 127.4%  
Foreign collaborators % 0.0 0.0 -  
Indian inst/Mut Fund % 4.7 8.0 59.1%  
FIIs % 7.5 27.7 27.1%  
ADR/GDR % 0.0 0.0 -  
Free float % 19.0 10.2 186.3%  
Shareholders   23,730 69,601 34.1%  
Pledged promoter(s) holding % 0.0 8.6 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare FDC LTD. With:   ALKEM LABORATORIES  PLETHICO PHARMA  WOCKHARDT LTD.  TORRENT PHARMA  FRESENIUS KABI ONCO.  

Compare FDC LTD. With:   ADCOCK INGRAM (S. Africa)  MYLAN (US)  ACTAVIS (US)  TEVA PHARMA (Israel)  



Today's Market

Post Noon Sell-Off; Infosys Falls 5.4%(Closing)

Share markets in India witnessed a sharp fall in the final minutes of trade. At the closing bell, the BSE Sensex closed lower by 266 points. While, the NSE Nifty finished lower by 83 points.

Related Views on News

Sun Pharma: Bottomline Slips into the Red Amidst Challenging Environment (Quarterly Results Update - Detailed)

Aug 14, 2017

A challenging environment and one-time expense pushes Sun Pharma into a loss in the first quarter.

Lupin: Bigger Challenges or Bigger Margin of Safety? (Quarterly Results Update - Detailed)

Aug 14, 2017

GST impact coupled with price erosion in US leads to lower profits for the quarter.

Dr Reddy's: US Pressure Continues to Haunt (Quarterly Results Update - Detailed)

Aug 8, 2017

Profits plunge due to higher raw material costs.

Biocon: Lower Licensing Income Leads to Muted Growth for the Quarter (Quarterly Results Update - Detailed)

Jun 23, 2017

Net Profit lower due to exceptional items in the previous year.

The Power of 5 Minutes (The 5 Minute Wrapup)

Jun 16, 2017

Here's what you can expect from The 5 Minute Wrapup in the coming months and years.

More Views on News

Most Popular

A 'Backdoor' to Multibaggers: It's Like Investing in Asian Paints Ten Years Ago(The 5 Minute Wrapup)

Aug 10, 2017

Don't miss these proxy bets on growing companies or in a few years you will be looking back with regret.

The Most Profitable Investment in the History of the World(Vivek Kaul's Diary)

Aug 8, 2017

'Yes, it looks like a bubble. And, yes, it's like buying a lottery ticket. But there's something happening that has never happened before. It's an evolutionary leap in money itself.'

Should You Invest In Bharat-22 ETF? Know Here...(Outside View)

Aug 8, 2017

Bharat-22 is one of the most diverse ETFs offered so far by the Government. Know here if you should invest...

Signs of Life in the India VIX(Daily Profit Hunter)

Aug 12, 2017

The India VIX is up 36% in the last week. Fear has gone up but is still low by historical standards.

Bitcoin Continues Stellar Rise(Chart Of The Day)

Aug 10, 2017

Bitcoin hits an all-time high, is there more upside left?

More

Become A Smarter Investor In
Just 5 Minutes

Multibagger Stocks Guide 2017
Get our special report, Multibagger Stocks Guide (2017 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

FDC LTD. SHARE PRICE


Aug 21, 2017 03:37 PM

TRACK FDC LTD.

  • Track your investment in FDC LTD. with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

FDC LTD. 8-QTR ANALYSIS

COMPARE FDC LTD. WITH

MARKET STATS